FreeTender
Accepting bidsgrantUnited States

CFAs: Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (United States)

Published
17 Nov 2026
Closes
10 Jun 2027
Reference
advancing-real-world-effectiveness-evidence-for-rapid-acting-psychotropic
Location
United States
Sector
Healthcare & Pharma

At a glance

A buyer in United States has published a funding call in healthcare & pharma: “CFAs: Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (United States)”. Submissions close on 10 June 2027, 205 days from today. Quote reference advancing-real-world-effectiveness-evidence-for-rapid-acting-psychotropic in any correspondence with the buyer. There are 385 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through fundsforNGOs — grants & funding calls, not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

Who can apply

Eligible applicants include various educational institutions, nonprofits, government entities, and organizations as specified above.

Details

The National Institutes of Health (NIH) is inviting applications for the “Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)” initiative. This opportunity seeks to establish a Clinical Trials Network to generate practical evidence for the safe and effective implementation of rapid-acting psychotropic drugs in routine clinical settings. Applications are due by 10 June 2027. This funding opportunity aims to create a network focused on rapid-acting psychotropic interventional drugs. The overarching goal is to develop actionable, real-world evidence to ensure these treatments can be effectively and safely delivered outside strict experimental settings. The program consists of two stages: an initial two-year phase for network establishment and pilot studies, followed by a three-year phase for the execution of large-scale pragmatic trials.

Eligible applicants include:

The program supports activities that aim to: This initiative is crucial for advancing mental health treatments by providing evidence for the practical use of RAPIDs. It addresses the need for treatments to be delivered in diverse clinical settings, enhancing their accessibility and effectiveness beyond controlled trials. What is the application deadline? The deadline for applications is 10 June 2027. Who can apply for this funding? Eligible applicants include various educational institutions, nonprofits, government entities, and organizations as specified above. What is the total funding available? The total estimated program funding is $12,000,000. What is the purpose of this funding opportunity? The purpose is to establish a network for RAPIDs to generate evidence for their effective implementation in real-world clinical settings. Where can I find more information? Visit the official opportunity page on Grants.gov for detailed information. Eligible applicants are encouraged to thoroughly review the official guidelines and ensure their applications are complete and submitted by the deadline. For further assistance, contact the Division of Services and Intervention Research at NIMHRAPIDS@nih.gov.

Context for bidders

There are 385 open Healthcare & Pharma tenders in United States. This one closes in 205 days.

Explore United States

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →